Comparing the difference of adverse events with HER2 inhibitors: a study of the FDA adverse event reporting system (FAERS)

Comparing the difference of adverse events with HER2 inhibitors: a study of the FDA adverse event reporting system (FAERS)

Aim and background: This study attempted to identify similarities and differences in adverse events (AEs) between human epidermal growth factor receptor 2 (HER2) inhibitors, especially those related to hemorrhagic events and nervous system disorders.Methods: This study summarized the types, frequenc...

Full description

Bibliographic Details
Main Authors: Yiwen Bao, Jiaju Chen, Luting Duan, Fujue Wang, Han Lai, Zeming Mo, Weiliang Zhu
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Pharmacology
Subjects:
HER2 inhibitors
FAERS database
adverse drug events
hemorrhagic events
nervous system disorders
TDM-1
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2024.1288362/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2024.1288362/full

Similar Items